Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Lückel, Christina
Altres autors: Huber, Magdalena (Prof. Dr.) (Assessor de tesis)
Format: Dissertation
Idioma:anglès
Publicat: Philipps-Universität Marburg 2018
Matèries:
Accés en línia:PDF a text complet
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

PDF a text complet

Detall dels fons de
Signatura: urn:nbn:de:hebis:04-z2018-03301
Data de publicació: 2019-02-28
Datum der Annahme: 2018-08-15
Downloads: 56 (2024), 86 (2023), 69 (2022), 72 (2021), 76 (2020), 69 (2019)
Lizenz: https://creativecommons.org/licenses/by-nc-sa/4.0
URL d'accés: https://archiv.ub.uni-marburg.de/diss/z2018/0330
https://doi.org/10.17192/z2018.0330